Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton's tyrosine kinase (BTK) signaling.

MLA

Hsu, Jonathan, et al. “Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)-Bruton’s Tyrosine Kinase (BTK) Signaling.” Journal of Biomolecular Screening, vol. 18, no. 8, Sept. 2013, pp. 890–98. EBSCOhost, https://doi.org/10.1177/1087057113489881.

APA

Hsu, J., Zhang, J., Kitson, C., Tan, S.-L., Narula, S., DeMartino, J. A., & Liao, C. (2013). Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton’s tyrosine kinase (BTK) signaling. Journal of Biomolecular Screening, 18(8), 890–898. https://doi.org/10.1177/1087057113489881

Chicago

Hsu, Jonathan, Jun Zhang, Chris Kitson, Seng-Lai Tan, Satwant Narula, Julie A DeMartino, and Cheng Liao. 2013. “Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)-Bruton’s Tyrosine Kinase (BTK) Signaling.” Journal of Biomolecular Screening 18 (8): 890–98. doi:10.1177/1087057113489881.